Daniel J. Campbell

Thomas Jefferson University Hospital

Papers

1

Total Citations

24

H-Index

1

About

Dr. Daniel J. Campbell is a leading otolaryngologist and head and neck surgeon whose research focuses on optimizing treatment paradigms for oropharyngeal squamous cell carcinoma (OPSCC). His most impactful work directly addresses a critical clinical dilemma: whether patients with early-stage (T1-T2) OPSCC fare better with primary transoral robotic surgery (TORS) or chemoradiation therapy. In a landmark 2023 study (24 citations), Dr. Campbell demonstrated that while survival outcomes are comparable between the two modalities, functional outcomes—such as swallowing and speech preservation—differ significantly, providing crucial, evidence-based guidance for shared decision-making in the absence of high-powered randomized trials. This work has rapidly shaped clinical protocols and sparked further investigation into patient-specific treatment selection. Dr. Campbell’s contributions are vital for advancing personalized care in head and neck oncology, bridging the gap between surgical innovation and radiation oncology to improve both survival and quality of life for his patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma
24 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Thomas Jefferson University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago